EUCTR2004-002714-11-IT进行中（未招募）1 期
Primary chemotherapy with temozolomide vs. radiotherapy in patients with lowgrade gliomas after stratification for genetic 1p loss: a phase III study
E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER0 个研究点目标入组 707 人开始时间: 2005年6月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 707
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss: a phase III studyEUCTR2004-002714-11-GBEuropean Organisation for Research and Treatment of Cancer707
进行中（未招募）
1 期
Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss: a phase III studyHistologically proven low-grade glioma ? Astrocytoma WHO grade II (gemistocytic, fibrillary and protoplasmatic) ? Oligoastrocytoma WHO grade II ? Oligodendroglioma WHO grade IIMedDRA version: 7.1Level: LLTClassification code 10025783EUCTR2004-002714-11-PTEuropean Organisation for Research and Treatment of Cancer707
进行中（未招募）
1 期
Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss: a phase III studyHistologically proven low-grade glioma ? Astrocytoma WHO grade II (gemistocytic, fibrillary and protoplasmatic) ? Oligoastrocytoma WHO grade II ? Oligodendroglioma WHO grade IIMedDRA version: 7.1Level: LLTClassification code 10025783EUCTR2004-002714-11-GREuropean Organisation for Research and Treatment of Cancer707
进行中（未招募）
不适用
Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss: a phase III studyHistologically proven low-grade glioma ? Astrocytoma WHO grade II (gemistocytic, fibrillary and protoplasmatic) ? Oligoastrocytoma WHO grade II ? Oligodendroglioma WHO grade IIMedDRA version: 7.1Level: LLTClassification code 10025783EUCTR2004-002714-11-HUEuropean Organisation for Research and Treatment of Cancer699
进行中（未招募）
不适用
Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss: a phase III studyHistologically proven low-grade glioma ? Astrocytoma WHO grade II (gemistocytic, fibrillary and protoplasmatic) ? Oligoastrocytoma WHO grade II ? Oligodendroglioma WHO grade IIMedDRA version: 7.1Level: LLTClassification code 10025783EUCTR2004-002714-11-DEEuropean Organisation for Research and Treatment of Cancer699